Skip to main content
Home
Browse by Topic
Issues
Online First
Latest Issue
Issue Archive
Special Issues
PSS Guide
Index
Introduction
Special Series
OFS Summit
Conference Correspondent
SABCS 2023 - HER2+ MBC
SABCS 2023 - HR+/HER2- MBC
ESMO 2023 - Small Cell Lung Cancer
ASCO 2023 - Breast Cancer
Monthly Minutes
Gastrointestinal Cancer
Lung Cancer
Multiple Myeloma
Women's Health
Multimedia
All Videos
Interview with the Innovators
Rapid Reactions
Webinars
Subscribe
Home
Browse by Topic
Issues
Online First
Latest Issue
Issue Archive
Special Issues
PSS Guide
Index
Introduction
Special Series
OFS Summit
Conference Correspondent
SABCS 2023 - HER2+ MBC
SABCS 2023 - HR+/HER2- MBC
ESMO 2023 - Small Cell Lung Cancer
ASCO 2023 - Breast Cancer
Monthly Minutes
Gastrointestinal Cancer
Lung Cancer
Multiple Myeloma
Women's Health
Multimedia
All Videos
Interview with the Innovators
Rapid Reactions
Webinars
Subscribe
Dalia Buffery, MA, ABD
VP, Senior Editorial Director
The Lynx Group
Authored Items
New Indications Approved by the FDA in 2018 for Oncology Drugs
By
Dalia Buffery, MA, ABD
2019 Fourth Annual Oncology Guide to New FDA Approvals
FDA Approvals, News & Updates
Introduction
Oncology Overview
Breast Cancer New Indications
Genitourinary Cancers New Indications
Gynecologic Cancers New Indications
Hematologic Malignancies New Indications
Lung Cancer New Indications
Other Tumor Types New Indications
Read Bio ›